Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Apr 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5035981014 | Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5035982019 | Metoprolol tartrate (as metoprolol succinate) 50 mg and telmisartan 40 mg conventional release and prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Is a | Product containing only metoprolol and telmisartan in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has manufactured dose form | Conventional release and prolonged-release oral tablet | true | Inferred relationship | Some | ||
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Telmisartan (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Telmisartan (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has precise active ingredient | Metoprolol succinate (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Metoprolol tartrate | true | Inferred relationship | Some | 2 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR